Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Methylphenidate, Rivastigmine or Haloperidol in Hypoactive Delirium in Intensive Care Patients

This study has been terminated.
(Inclusion rate too low due to a lack of eligible patients and difficulties obtaining informed consent.)
Sponsor:
Information provided by:
UMC Utrecht
ClinicalTrials.gov Identifier:
NCT00599287
First received: January 10, 2008
Last updated: May 27, 2008
Last verified: February 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2008
  Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)